Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.

Autor: Zhou B; Immunology Program, Benaroya Research Institute, Seattle, Washington 98101, USA., Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF
Jazyk: angličtina
Zdroj: Nature immunology [Nat Immunol] 2005 Oct; Vol. 6 (10), pp. 1047-53. Date of Electronic Publication: 2005 Sep 04.
DOI: 10.1038/ni1247
Abstrakt: The cytokine thymic stromal lymphopoietin (TSLP) has been linked to human allergic inflammatory diseases. We show here that TSLP expression was increased in the lungs of mice with antigen-induced asthma, whereas TSLP receptor-deficient mice had considerably attenuated disease. Lung-specific expression of a Tslp transgene induced airway inflammation and hyperreactivity characterized by T helper type 2 cytokines and increased immunoglobulin E. The lungs of Tslp-transgenic mice showed massive infiltration of leukocytes, goblet cell hyperplasia and subepithelial fibrosis. TSLP was capable of activating bone marrow-derived dendritic cells to upregulate costimulatory molecules and produce the T helper type 2 cell-attracting chemokine CCL17. These findings suggest that TSLP is an important factor necessary and sufficient for the initiation of allergic airway inflammation.
Databáze: MEDLINE